Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration

por Mariko Yamashita, Masanori Matsumoto, Masaki Hayakawa, Kazuya Sakai, Yoshihiro Fujimura, Nahoko Ogata
Publicado 2018

Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration

por Hiromasa Hirai, Mariko Yamashita, Masanori Matsumoto, Masaki Hayakawa, Kazuya Sakai, Tetsuo Ueda, Nahoko Ogata
Publicado 2021

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.

por Kei Takayama, Hideaki Someya, Hiroshi Yokoyama, Takeshi Kimura, Yoshihiro Takamura, Masakazu Morioka, Hiroto Terasaki, Tetsuo Ueda, Nahoko Ogata, Shigehiko Kitano, Maki Tashiro, Taiji Sakamoto, Masaru Takeuchi
Publicado 2021